Management of Disseminated Fungal Disease in Renal Transplant Recipients: A Case Series (ATC 2026) - Jun 17, 2026 - Abstract #Abstract D167; Pres time: Jun 23, 2026; 02:30 PM - 03:30 PM; Location: Exhibit Hall; "( Picture 1).He required ventilatory and hemodynamic support but stabilized under aggressive therapy with amphotericin B, micafungin, and voriconazole while immunosuppression was held...Despite early initiation of isavuconazole followed by amphotericin B and intensive supportive care, he deteriorated and died on hospital day 45.* Disseminated fungal infections in renal transplant recipients present significant diagnostic and therapeutic challenges. Disseminated fungal infections in renal transplant recipients present significant diagnostic and therapeutic challenges. IA may manifest later post-transplant with potential for recovery under aggressive therapy, while mucormycosis can occur early and progress rapidly, often resulting in poor outcomes despite prompt treatment. These cases underscore the importance of early recognition, rapid antifungal therapy, multidisciplinary management, and careful balancing of immunosuppression to optimize survival and graft function..."
Clinical • Infectious Disease • Nephrology • Respiratory Diseases • Transplantation
|
|
H. Soliman 1; R. S. Raman 2; M. A. Alfaqih 2; P. Singh 3; R. Shahbazov 2
|